← Back to Clinical Trials
Recruiting NCT06551870

NCT06551870 Xbox Kinect Sports Versus Nintendo Switch Sports

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06551870
Status Recruiting
Phase
Sponsor Universidad Católica del Maule
Condition Healthy People Programs
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2024-04-14
Primary Completion 2024-12-14

Eligibility & Interventions

Sex Female only
Min Age 60 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
Physical activity

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2024-04-14 with a primary completion date of 2024-12-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study will be to compare the effects of Xbox Kinect Sports (XKS) with respect to Nintendo Switch Sports (NSS) and the inactive control group (CG) on body composition (percent body fat and fat-free mass) and physical performance (hand grip strength, HGS; 30 seconds standing in a chair, timed get up and walk, TUG; sit and reach and 2-minute step test) in physically inactive older women. This study will be randomized controlled trial with three parallel groups: XKS (n= 13), NSS (n= 14) and CG (n= 16).

Eligibility Criteria

Inclusion Criteria: * Older female aged between 60 and 75 years old. * Presenting the ability to understand and execute direct commands in a contextualized manner. * Independent, that is, have a score equal to or greater than 43 points in the Preventive Medicine Exam for the Older People (in Spanish, EMPAM) of the Ministry of Health (Ministerio de Salud, 2013). * Did not present any visual difficulty and/or any vestibular alteration that would hinder the performance of the games in front of the screen- * Complying with at least 85% attendance at the sessions scheduled for interventions. Exclusion Criteria: * Having any disabling disease. * Those female who have musculoskeletal injuries or who are undergoing physical rehabilitation treatment that prevents their normal physical performance. * Those who have permanent or temporary contraindications to perform physical activity.

Contact & Investigator

Central Contact

Pablo Valdés-Badilla, PhD

✉ valdesbadilla@gmail.com

📞 +56971258824

Principal Investigator

Pablo Valdés-Badilla, PhD

PRINCIPAL INVESTIGATOR

Universidad Católica del Maule

Frequently Asked Questions

Who can join the NCT06551870 clinical trial?

This trial is open to female participants only, aged 60 Years or older, up to 75 Years, studying Healthy People Programs. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06551870 currently recruiting?

Yes, NCT06551870 is actively recruiting participants. Contact the research team at valdesbadilla@gmail.com for enrollment information.

Where is the NCT06551870 trial being conducted?

This trial is being conducted at Osorno, Chile.

Who is sponsoring the NCT06551870 clinical trial?

NCT06551870 is sponsored by Universidad Católica del Maule. The principal investigator is Pablo Valdés-Badilla, PhD at Universidad Católica del Maule. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology